|
Volumn 51, Issue 3, 2002, Pages 191-202
|
The use of arginine vasopressin during cardiopulmonary resuscitation. An analysis of experimental and clinical experience and a view into the future;Der einsatz von arginin vasopressin bei der kardiopulmonalen reanimation. Eine analyse der experimentellen und klinischen erfahrungen sowie ein ausblick in die zukunft
a a a a a a a |
Author keywords
Clinical recommendation; Endocrinology; Epinephrine; Intraosseous; Postresuscitation phase; Pulseless electrical activity; Randomized controlled trial; Survival; Vasopressor; Ventricular fibrillation
|
Indexed keywords
ADRENALIN;
ARGIPRESSIN;
BETA ADRENERGIC RECEPTOR;
CORTICOTROPIN;
DESMOPRESSIN;
ENDOTHELIN;
HYDROCORTISONE;
NORADRENALIN;
OXYTOCIN;
ASYSTOLE;
BLOOD LEVEL;
CLINICAL TRIAL;
CORONARY ARTERY BLOOD FLOW;
DRUG EFFECT;
DRUG UTILIZATION;
EXPERIMENTAL MODEL;
HEART ARREST;
HEART FAILURE;
HEART MUSCLE OXYGEN CONSUMPTION;
HEART VENTRICLE ARRHYTHMIA;
HEART VENTRICLE FIBRILLATION;
HOMEOSTASIS;
HUMAN;
LUNG VENTILATION PERFUSION RATIO;
NONHUMAN;
ORGAN BLOOD FLOW;
OUTCOMES RESEARCH;
PRACTICE GUIDELINE;
RESUSCITATION;
REVIEW;
RISK BENEFIT ANALYSIS;
SPLANCHNIC BLOOD FLOW;
SURVIVAL RATE;
SYSTEMIC VASCULAR RESISTANCE;
ANIMALS;
ARGININE VASOPRESSIN;
CARDIOPULMONARY RESUSCITATION;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
VASOCONSTRICTOR AGENTS;
|
EID: 0036210530
PISSN: 00032417
EISSN: None
Source Type: Journal
DOI: 10.1007/s00101-002-0287-8 Document Type: Review |
Times cited : (17)
|
References (30)
|